Enhancing groundwater vulnerability assessment for improved environmental management: addressing a critical environmental concern.

Groundwater serves as a primary water source for various purposes. Therefore, aquifer pollution poses a critical threat to human health and the environment. Identifying the aquifer's highly vulnerable areas to pollution is necessary to implement appropriate remedial measures, thus ensuring groundwater sustainability. This paper aims to enhance groundwater vulnerability assessment (GWVA) to manage aquifer quality effectively. The study focuses on the El Orjane Aquifer in the Moulouya basin, Morocco, which is facing significant degradation due to olive mill wastewater. Groundwater vulnerability maps (GVMs) were generated using the DRASTIC, Pesticide DRASTIC, SINTACS, and SI methods. To assess the effectiveness of the proposed improvements, 24 piezometers were installed to measure nitrate concentrations, a common indicator of groundwater contamination. This study aimed to enhance GWVA by incorporating new layers, such as land use, and adjusting parameter rates based on a comprehensive sensitivity analysis. The results demonstrate a significant increase in Pearson correlation values (PCV) between the produced GVMs and measured nitrate concentrations. For instance, the PCV for the DRASTIC method improved from 0.42 to 0.75 after adding the land use layer and adjusting parameter rates using the Wilcoxon method. These findings offer valuable insights for accurately assessing groundwater vulnerability in areas with similar hazards and hydrological conditions, particularly in semi-arid and arid regions. They contribute to improving groundwater and environmental management practices, ensuring the long-term sustainability of aquifers.

Effectiveness and Safety of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) among Healthcare Workers: A Seven-Month Follow-Up Study at Fifteen Central Hospitals.

BACKGROUND: During a pandemic, healthcare workers are at high risk of contracting COVID-19. To protect these important individuals, it is highly recommended that they receive the COVID-19 vaccine. Our study focused on evaluating the safety and efficacy of Egypt's first approved vaccine, the Sinopharm vaccine (BBIBP-CorV), and comparing these findings with other vaccines. METHODS: An observational study was conducted in fifteen triage and isolation hospitals, from the 1st of March until the end of September 2021. The study included fully vaccinated and unvaccinated participants, and we measured vaccine effectiveness (using 1-aHR), the incidence rate of severely to critically ill hospitalized cases, COVID-19-related work absenteeism, and the safety of the vaccine as outcomes. RESULTS: Of the 1364 healthcare workers who were interviewed, 1228 agreed to participate. After taking the hazard ratio into account, the vaccine effectiveness was found to be 67% (95% CI, 80-43%) for symptomatic PCR-confirmed cases. The incidence rate ratio for hospitalization was 0.45 (95% CI, 0.15-1.31) in the vaccinated group compared to the unvaccinated group, and there was a significant reduction in absenteeism among the vaccinated group (p < 0.007). Most adverse events were mild and well tolerated. Vaccinated pregnant and lactating mothers did not experience any sentinel adverse events. CONCLUSION: Our study found that the BBIBP-CorV vaccine was effective in protecting healthcare workers from COVID-19.